Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 5% imiquimod for infantile hemangioma
2004-001262-40Phase 4Active
- Sponsor
- Investigador del estudio: Dr. AgustÃn Alomar Muntañola
- Start
- Dec 2005
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imiquimod in Capillary Haemangioma, sponsored by Investigador del estudio: Dr. AgustÃn Alomar Muntañola. Primary endpoint: Complete regression of treated hemangiomas. Started Dec 2005; status: active.
02
Drugs
imiquimod
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on 2004-001262-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001262-40.